HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alphonso, N. Articles by Anderson, D. Search for Related Content PubMed PubMed Citation Articles by Alphonso, N. Articles by Anderson, D. Related Collections Cardiac - other Valve disease

Eur J Cardiothorac Surg 2004;25:925-930
© 2004 Elsevier Science NL

Midterm results of the Ross procedure

Department of Congenital Heart Disease, Guy's Hospital, Guy's and St Thomas Hospitals NHS Trust, St Thomas' Street, London SE1 9RT, UK

Received 17 October 2003; received in revised form 12 January 2004; accepted 23 January 2004.

^* Corresponding author. Flat 47, Royal Park Towers, 171 Flemington Road, North Melbourne, Vic. 3051, Australia. Tel.: +61-3-9329-9742; fax: +61-3-9345-6386
e-mail: nelson.a{at}bigfoot.com

Objective: The lack of durable bioprosthetic valves and the inherent risks associated with anticoagulation for mechanical valves have led to the continued use of the Ross procedure, particularly in the pediatric population. Methods: We have reviewed our mid-term results retrospectively, following the Ross operation in both pediatric and adult groups. Results: Over a 11-year period from August 1991 to August 2002, 60 patients underwent the Ross procedure. The median age was 15 years (6–804 months), of which 63% were males and 55% were under the age of 20 years. The main indications were: aortic stenosis in 47 patients; aortic insufficiency in 6 patients; and mixed aortic valve disease in 28 patients. Fifteen patients had previously undergone balloon dilatation of the aortic valve, 4 had open valvotomy and 3 had both valvuloplasty procedures. The pulmonary autograft was implanted as a sub-coronary implant until 1995 (30%) after which time it was implanted using a partial inclusion cylinder technique (70%). There have been no deaths reported in this series. Over a median follow-up period of 59 months (2–122 months), there have been four re-operations for repair of autograft leak, and 2 adult patients have had autograft replacements. Conclusions: Despite the increased technical complexity, the Ross procedure can be performed safely in both paediatric and adult populations with satisfactory medium term results.

Key Words: Aortic valve disease • Ross procedure • Pulmonary autograft • Homograft

This article has been cited by other articles:

				R. Wang, A. Farnsworth, and H. Albrecht Mid-term results of ross procedure: our limited experience. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 289 - 293. [Abstract] [Full Text] [PDF]

				M. G. Hazekamp, H. B. Grotenhuis, P. H. Schoof, M. E.B. Rijlaarsdam, J. Ottenkamp, and R. A.E. Dion Results of the Ross operation in a pediatric population Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 975 - 979. [Abstract] [Full Text] [PDF]

				F. Dagenais, P. Cartier, P. Voisine, D. Desaulniers, J. Perron, R. Baillot, G. Raymond, J. Metras, D. Doyle, and P. Mathieu Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1041 - 1049. [Abstract] [Full Text] [PDF]